La presente informativa è resa, anche ai sensi dell’art. 13 del D. Lgs. 196/2003 “Codice in materia di protezione dei dati personali” (“Codice Privacy”) 
e degli artt. 13 e 14 del Regolamento (UE) 2016/679 (“GDPR”), a coloro che si collegano alla presente edizione online del giornale Tribuna Economica di proprietà di AFC Editore Soc. Coop. 

Leggi di più

I TWEET

Scenario economico romeno e futuro dei rapporti con il nostro Paese. I principali temi dell'intervista di… https://t.co/LuvnTpmEwh
Primo portafoglio acquistato da #AMCO composto da crediti deteriorati di #BancaCarige https://t.co/H1hkkrGnJv via @TribunaEconomic
46 miliardi di Risorse Mobilitate, l’impegno di @SACEgroup a sostegno del #SistemaPaese https://t.co/NLaTjfoJB6’im… https://t.co/js1pybEMYn

The European Investment Bank (EIB) is providing Novozymes, a Copenhagen-based industrial enzymes company, with EUR 100m in financing to boost its research and development activities in industrial enzymes and microorganisms. The EIB loan will support Novozymes in maintaining the high quality of

its research and development activities, retaining its global technology leadership and long-term competitiveness and thus creating conditions for further economic growth and employment in Europe.

 

Enzyme-assisted products and processes enjoy increasing demand, as they can replace more environmentally intrusive conventional chemicals, or more energy-intensive processes. In nature, enzymes catalyse biochemical reactions. They convert food in our stomachs into energy and turn fallen leaves into compost. In industry, enzymes replace chemicals and accelerate production processes. They help companies produce more, while using less water, energy and raw materials with a technology that replaces conventional chemicals and reduces environmental impact.